Centene Co. (NYSE:CNC - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Centene in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst S. James anticipates that the company will post earnings of $8.26 per share for the year. The consensus estimate for Centene's current full-year earnings is $6.86 per share.
Other analysts also recently issued reports about the stock. Wall Street Zen downgraded shares of Centene from a "strong-buy" rating to a "buy" rating in a report on Monday, April 28th. Barclays reaffirmed an "equal weight" rating and set a $65.00 price target (down from $84.00) on shares of Centene in a research report on Monday, June 2nd. Morgan Stanley began coverage on Centene in a research report on Monday. They issued an "overweight" rating and a $70.00 price objective for the company. Guggenheim reaffirmed a "neutral" rating on shares of Centene in a report on Tuesday, April 29th. Finally, Wells Fargo & Company lowered their price target on shares of Centene from $76.00 to $72.00 and set an "overweight" rating on the stock in a research report on Friday, February 14th. Seven equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, Centene currently has an average rating of "Moderate Buy" and an average price target of $77.71.
Get Our Latest Stock Analysis on Centene
Centene Stock Down 0.5%
Shares of NYSE:CNC traded down $0.27 during trading on Tuesday, hitting $55.49. 2,416,425 shares of the company's stock traded hands, compared to its average volume of 4,890,234. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. The company has a 50-day moving average price of $59.86 and a 200-day moving average price of $60.06. Centene has a 52 week low of $54.01 and a 52 week high of $80.59. The company has a market cap of $27.61 billion, a price-to-earnings ratio of 8.89, a price-to-earnings-growth ratio of 0.80 and a beta of 0.45.
Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $2.90 earnings per share for the quarter, topping analysts' consensus estimates of $2.52 by $0.38. Centene had a net margin of 2.03% and a return on equity of 13.85%. The company had revenue of $46.62 billion for the quarter, compared to analysts' expectations of $43.16 billion. During the same period last year, the firm posted $2.26 earnings per share. The business's quarterly revenue was up 15.4% compared to the same quarter last year.
Institutional Investors Weigh In On Centene
A number of institutional investors have recently modified their holdings of the company. Hussman Strategic Advisors Inc. bought a new stake in Centene during the fourth quarter valued at $1,272,000. Bonfire Financial acquired a new position in shares of Centene in the 4th quarter valued at about $490,000. Empirical Finance LLC grew its stake in Centene by 38.4% during the fourth quarter. Empirical Finance LLC now owns 26,034 shares of the company's stock worth $1,577,000 after purchasing an additional 7,229 shares during the period. Captrust Financial Advisors increased its holdings in Centene by 55.6% in the fourth quarter. Captrust Financial Advisors now owns 45,103 shares of the company's stock worth $2,732,000 after purchasing an additional 16,108 shares in the last quarter. Finally, Diametric Capital LP acquired a new position in Centene in the fourth quarter valued at approximately $610,000. 93.63% of the stock is owned by institutional investors.
About Centene
(
Get Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Recommended Stories

Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.